Scientist at IMBA developed a biobank of revertible, mutant embryonic stem cells, published in the current issue of Nature. This cell bank – called Haplobank – contains over 100,000 mutated, conditional mouse embryonic stem cell lines, targeting about 70 percent of the protein-coding genome.